A color-coded orthotopic nude-mouse treatment model of brain-metastatic paralyzing spinal cord cancer that induces angiogenesis and neurogenesis

Cell Proliferation

Volumn 42, Issue 1, 2009, Pages 75-82

  Hayashi, K ^a,b,c   Yamauchi, K ^c   Yamamoto, N ^c   Tsuchiya, H ^c   Tomita, K ^c   Bouvet, M ^a   Wessels, J ^d   Hoffman, R M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; TEMOZOLOMIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUDE MOUSE; PARALYSIS; PROTEIN EXPRESSION; SPINAL CORD CANCER; SPINAL CORD GLIOMA; TRANSGENIC MOUSE;

ANIMALS; BRAIN NEOPLASMS; COLOR; DISEASE MODELS, ANIMAL; FEMALE; GLIOMA; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SPINAL CORD NEOPLASMS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 58449124193     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2008.00574.x     Document Type: Article

References (17)

1. McLaughlin MP, Buatti JM, Marcus RB Jr., Maria BL, Mickle PJ, Kedar A (1998) Outcome after radiotherapy of primary spinal cord glial tumors. Radiat. Oncol. Investig. 6, 276 280.
2. Shirato H, Kamada T, Hida K, Koyanagi I, Iwasaki Y, Miyasaka K, Abe H (1995) The role of radiotherapy in the management of spinal cord glioma. Int. J. Radiat. Oncol. Biol. Phys. 33, 323 328.
3. Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ (2000) Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J. Neurosurg. 93, 183 193.
4. Epstein FJ, Farmer J-P (1990) Pediatric spinal cord tumor surgery. Neurosurg. Clin. N. Am. 1, 569 590.
5. Caplan J, Pradilla G, Hdeib A, Tyler BM, Legnani FG, Bagley CA, Brem H, Jallo G (2006) A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization. Neurosurgery 59, 193 200.
6. Mavinkurve G, Pradilla G, Legnani FG, Tyler BM, Bagley CA, Brem H, Jallo G (2005) A novel intramedullary spinal cord tumor model: functional, radiological, and histopathological characterization. J. Neurosurg. Spine 3, 142 148.
7. Cheng CL, Johnson SP, Keir ST, Quinn JA, Ali-Osman F, Szabo C, Li H, Salzman AL, Dolan ME, Modrich P, Bigner DD, Friedman HS (2005) Poly (ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol. Cancer Ther. 4, 1364 1368.
8. Momota H, Nerio E, Holland EC (2005) Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo. Cancer Res. 65, 7429 7435.
9. Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244 256.
10. Li L, Mignone J, Yang M, Matic M, Penman S, Enikolopov G, Hoffman RM (2003) Nestin expression in hair follicle sheath progenitor cells. Proc. Natl. Acad. Sci. USA 100, 9958 9961.
11. Amoh Y, Li L, Yang M, Moossa AR, Katsuoka K, Penman S, Hoffman RM (2004) Nascent blood vessels in the skin arise from nestin-expressing hair follicle cells. Proc. Natl. Acad. Sci. USA 101, 13291 13295.
12. Amoh Y, Yang M, Li L, Reynoso J, Bouvet M, Moossa AR, Katsuoka K, Hoffman RM (2005) Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res. 65, 5352 5357.
13. Kawahara N, Tomita K, Shinya Y, Matsumoto T, Baba H, Fujita T, Murakami H, Kobayashi T (1999) Recapping T-Saw laminoplasty for spinal cord tumors. Spine 24, 1363 1370.
14. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, CaiRncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987 996.
15. Yang M, Jiang P, Sun FX, Hasegawa S, Baranov E, Chishima T, Shimada H, Moossa AR, Hoffman RM (1999a) A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res. 59, 781 786.
16. Yang M, Jiang P, An Z, Baranov E, Li L, Hasegawa S, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR, Hoffman RM (1999b) Genetically fluorescent melanoma bone and organ metastasis models. Clin. Cancer Res. 5, 3549 3559.
17. Cruz-Munoz W, Man S, Xu P, Kerbel RS (2008) Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res. 68, 4500 4505.